Article by Martin & Mary Kelly, Current Examiners in P1 Corporate Reporting Relevant to the following subjects;

Similar documents
TAX IMPLICATIONS RELATED TO THE IMPLEMENTATION OF FRS 138: INTANGIBLE ASSETS

DISCUSSION PAPER TAX IMPLICATIONS RELATED TO THE IMPLEMENTATION OF FRS 138: INTANGIBLE ASSETS

Combined financial statements of the Galenica Santé Group 1. Combined financial statements of the Galenica Santé Group

Significant Accounting Policies

and Marking Scheme 40 Total equity and liabilities 1,700,530

STRUCTURED CONNECTIVITY SOLUTIONS (PTY) LTD (Registration number 2002/001640/07) Historical FInancial Information for the year ended 31 August 2012

Accounting policies STRATEGIC REPORT GOVERNANCE FINANCIAL STATEMENTS. inchcape.com 93

GEDEON RICHTER CONSOLIDATED FINANCIAL STATEMENTS

Cast. The following information has been extracted from Cast s financial statements for the year ended 31 March 2015

Pearson plc IFRS Technical Analysis

Financial statements. Consolidated financial statements. Company financial statements

INCOME TAX. Draft flow chart and illustrative examples. prepared by the IASB s staff March 2009

The consolidated financial statements of WPP plc

Our 2009 financial statements

A7 Accounting policies

GEDEON RICHTER CONSOLIDATED FINANCIAL STATEMENTS GEDEON RICHTER CONSOLIDATED FINANCIAL STATEMENTS

Diploma in International Financial Reporting and Marking Scheme

(a) Business combinations: those prior to the transition date have not been restated onto an IFRS basis.

The notes on pages 7 to 59 are an integral part of these consolidated financial statements

INFORMA 2017 FINANCIAL STATEMENTS 1

ACCOUNTING POLICIES. for the year ended 30 June MURRAY & ROBERTS ANNUAL FINANCIAL STATEMENTS 13

Coca-Cola Hellenic Bottling Company S.A Annual Report

Group Income Statement For the year ended 31 March 2015

Pearson plc IFRS Technical Analysis

The consolidated financial statements were authorised for issue by the Board of Directors on 1 June 2015.

Attributable to: Equity shareholders of Alpha 38,540 Minority interest (working 4) 5,300 43,840

IFRS hot topic... Licensors enter into various types of licensing agreements with third parties. These licensing agreements may be:

Statement of Comprehensive Income 1. Statement of Movements in Equity 1. Statement of Financial Position 2. Statement of Cash Flows 3

218/2-4 Moo 10 Beach Road, Nongprue, Banglamung, Chonburi, Thailand.

Consolidated Financial Statements of ANGOSTURA HOLDINGS LIMITED. December 31, 2014 (Expressed in Trinidad and Tobago Dollars)

For personal use only

Notes to the financial statements appendices

Consolidated income statement For the year ended 31 March

ACCOUNTING STANDARDS BY D.S. RAWAT FCA

Accounting policies for the year ended 30 June 2016

Introduction Consolidated statement of comprehensive income for the year ended 31 December 20XX... 6

Our 2017 consolidated financial statements

Attributable to Minority interest (4,200 x 20%) 840 Alpha shareholders (balance) 19,642 Net profit for the period 20,482

ACERINOX, S.A. AND SUBSIDIARIES. 31 December 2015

IFRS model financial statements 2017 Contents

Profit/(Loss) before income tax 112, ,323. Income tax benefit/(expense) 11 (31,173) (37,501)

UNITED INTERNATIONAL TRANSPORTATION COMPANY (A SAUDI JOINT STOCK COMPANY) AND IT S SUBSIDIARY

For personal use only

159 Company Income Statement 160 Company Balance Sheet 162 Notes to the Company Financial Statements

Accounting and Auditing Investing in Switzerland A guide for Chinese companies. Audit & Assurance

29 June SAVILLS PLC (Savills or 'The Group') ADOPTION OF INTERNATIONAL FINANCIAL REPORTING STANDARDS (IFRS)

In brief A look at current financial reporting issues

Mail.ru Group Limited. Consolidated Financial Statements. For the year ended December 31, 2018

Independent Auditor s report to the members of Standard Chartered PLC

Improvements to IFRSs PART I

Financial supplement NPM/CNP. Compagnie Nationale à Portefeuille Nationale PortefeuilleMaatschappij

10/24/2008. Reporting and. assets PROPERTY, PLANT AND EQUIPMENT. PROPERTY, PLANT AND EQUIPMENT continued. Chapter 8

IFRS-JGAAP comparison. English version 2.0 [equivalent of Japanese version 3.0]

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2014

Company Financial Statements. Subsidiaries 175 Joint Ventures and Associates 181

TAYSIDE HEALTH BOARD APPENDIX 1

Consolidated Financial Statements Summary and Notes

Tax Briefing No 09. This content is more than 5 years old. Where still relevant it has been incorporated. into a Tax and Duty Manual

Applying IFRS. Accounting by holders of crypto-assets. August 2018

Objective of IAS 18 The objective of IAS 18 is to prescribe the accounting treatment for revenue arising from certain types of transactions and events

Directors Report 3. Income Statements 4. Statements of Changes in Equity 5. Balance Sheets 6. Statements of Cash Flows 7-8

Group accounting policies

Non-current Assets Held for Sale and Discontinued Operations

Coca-Cola Hellenic Bottling Company S.A. Annual Report 2012 (IFRS Financial Statements)

Amadeus IT Group, S.A. Auditor s Report, Annual Accounts and Directors Report for the year ended December 31, 2018

DEOLEO, S.A. AND SUBSIDIARIES

ACCOUNTING POLICIES Year ended 31 March The numbers

EY IFRS Core Tools. IFRS Update of standards and interpretations in issue at 31 December 2014

In accordance with HKAS 38, an intangible asset possesses the following characteristics:

Consolidated Financial Statements

Mining and Metallurgical Company Norilsk Nickel. Consolidated financial statements for the year ended 31 December 2015

ACCOUNTING POLICIES 1 PRESENTATION OF FINANCIAL STATEMENTS. for the year ended 30 June BASIS OF PREPARATION 1.2 STATEMENT OF COMPLIANCE

Dallah Healthcare Company (A Saudi Joint Stock Company)

R&D; goodwill; intangible assets and brands

w:

HSBC Holdings plc IFRS Comparative Financial Information

Independent Auditor s Report

Gedeon Richter Consolidated Financial Statements 2014

Morse Investments (Proprietary) Limited (Registration number 2006/255) Financial statements for the period ended 30 September, 2016

Selecta Group B.V. and its subsidiaries, Amsterdam (The Netherlands)

Consolidated financial statements and independent auditor s report BORETS INTERNATIONAL LIMITED 31 December 2017

IFRS Update of standards and interpretations in issue at 30 June 2015

Non-current Assets Held for Sale and Discontinued Operations

NALCOR ENERGY - OIL AND GAS INC. FINANCIAL STATEMENTS December 31, 2017

Consolidated Financial Statements

Continuing operations Revenue 3(a) 464, ,991. Revenue 464, ,991

May & Baker Nig Plc RC. UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS 31 MARCH 2017

Professional Level Essentials Module, Paper P2 (INT)

Consolidated Financial Statements of ANGOSTURA HOLDINGS LIMITED. December 31, 2017 (Expressed in Trinidad and Tobago Dollars)

and Marking Scheme 36 Total equity and liabilities 1,604,100

GROUP FINANCIAL STATEMENTS 45

Non-current Assets Held for Sale and Discontinued Operations

Consolidated Cash Flow Statement

PAO SIBUR Holding. International Financial Reporting Standards Consolidated Financial Statements and Independent Auditor s Report.

For personal use only

Gedeon Richter CONSOLIDATED FINANCIAL STATEMENTS 2015

First-time Adoption of International Financial Reporting Standards

Saving our customers money so they can live better

Appendix 4E. Preliminary final report Current Reporting Period: 52 weeks ended 28 July 2018 Previous Corresponding Period: 52 weeks ended 29 July 2017

Monetary figures in the financial statements are expressed in millions of euros unless otherwise stated.

Transcription:

Article by Martin & Mary Kelly, Current Examiners in P1 Corporate Reporting Relevant to the following subjects; Professional 1: Corporate Reporting Professional 2: Advanced Corporate Reporting Intangible Assets Introduction In recent years the recognition and measurement of intangible assets has been one of the most controversial areas of financial reporting. Many businesses now operate and compete with significant intangible assets such as brands, knowledge capital and people. Chief executives of these businesses clearly accept that some intangibles, particularly internally generated ones, are difficult to value. However, there has been criticism that accounting practice in this area is out of date, unhelpful to users and in need of reform. It would appear that with regard to intangibles, reliability has superseded relevance. Intangible assets are identifiable non-monetary assets without a physical presence which have been created through time and expense, and can be identified as separate assets which will provide future economic benefits to the business. IAS 38, Intangible Assets, defines an intangible asset as an identifiable, non-monetary asset without physical substance Examples of assets that might be classified as intangible include patents, trademarks, import duties, fishing licences and computer software. Students often get confused as to how an intangible asset can be classified as non-monetary when we actually value them in the financial statements. The definition is highlighting that items such as cash, bank deposits and trade receivables are monetary assets and are therefore to be excluded. Goodwill and brand image are also examples of intangible assets which need to be identified separately before they can be included as assets of the business. Where goodwill and brands have been acquired externally, their cost and existence can be identified and capitalised. Internally generated goodwill cannot be recognised as an asset as it is not separable from the business nor has it arisen from contractual or other legal rights. Its cost cannot be measured reliably. IAS38 reflects the key principles outlined in the IASB Framework, for example, the definition of an asset is: a resource controlled by the entity as a result of past events from which future economic benefits will flow to the entity. Identifiably and Control An intangible asset must be identifiable. This is included in IAS38 in order to distinguish intangible assets from goodwill arising on business combinations. An asset is identifiable when it is separable (capable of being separated from the entity and sold) and it arises from contractual or other legal rights. Motion picture films, fishing licences and import quotas arise from contractual or legal rights. The second condition is designed to cover assets that are not separable, but are nevertheless valuable. An intangible asset must be under the control of the entity so the entity has the power to obtain the future economic benefits from the asset. This control will usually (but not necessarily) stem from legally enforceable rights. In the absence of such rights, it is more difficult to prove that an asset exists. For example:

- Control over technical knowledge or know-how only exists if it is protected by legal right such as copyright or a patent. - Expenditure on staff training courses may be expected to increase skills of the staff and generate future economic benefits. However, the entity incurring this expenditure may have little control over the staff, who could decide to move to a different employer. A similar issue arises in evidencing that an entity has sufficient control over market share and customer loyalty to meet the definition of an intangible asset. Recognition and Measurement An item is recognised as an intangible asset if it meets the definition of an intangible asset outlined above and also satisfies the usual recognition criteria for an asset outlined in the IASB Framework. In line with the Framework, IAS38 states an intangible asset should only be recognised if, and only if, BOTH the following occur: 1. It is probable that the future economic benefits that are attributable to the asset will flow to the entity, and 2. The cost can be measured reliably. Clearly management will have to exercise an element of judgement in assessing the degree of certainty attached to any expected economic benefits. IAS38 states that intangible assets should be measured initially at their cost. If an asset is acquired in a normal transaction, then the fact that a price has been paid for the asset, is a reflection of the expectation that future economic benefits will flow to the entity. In addition, the asset cost can usually be measured reliably. Mastheads, licences, copyrights, patents are all examples of assets that can be acquired externally and meet the recognition criteria. The cost of such assets comprises the purchase price (including duties and non-refundable taxes), and any directly attributable costs of preparing the asset for its intended use. An example of the latter cost would be legal and professional fees. Example 1 Aston Ltd acquires new energy efficient technology that will significantly reduce its energy costs for manufacturing. Costs incurred include: Cost of new solar technology 1,500,000 Trade discount provided 200,000 Training course for staff in new technology 70,000 Initial testing of new technology 20,000 Losses incurred while other parts of plant shut down during testing and training. 30,000 The cost that can be recognised and capitalised is: Cost 1,500,000 Less discount (200,000) Plus initial testing 20,000 1,320,000

An intangible asset may be acquired in a business combination. If an intangible asset is acquired in a business combination, the cost of the asset is specified by IAS38 (in accordance with IFRS3) to be its fair value on the date of acquisition. The fact that a price can be established for an intangible asset which is acquired in a business combination is accepted as evidence that future economic benefits are expected to accrue to the entity. Internally generated intangibles Internally generated goodwill can never be recognised as an asset (as per IAS38). The main problems in deciding whether internally generated assets are to be recognised are in terms of determining when an intangible comes into existence and measuring its cost reliably. IAS38 has therefore introduced additional requirements such that the internal generation of an asset should be classified into a research phase and a development phase. Note that these phrases relate to all intangibles, not just what would normally be regarded as research and development expenditure. Any expenditure that arises in the research phase should be recognised as an expense when incurred. The rationale being, there is insufficient certainty as to whether future economic benefits will occur. Examples of this type of activity are specifically outlined in the standard and include: Activities aimed at obtaining new knowledge; search for, evaluation and final selection of applications of research findings or other knowledge; search for alternatives for materials devices, products, processes or services. IAS 38 states that development costs qualify for recognition as intangible assets provided the following strict criteria apply. These include: Example 2 Technical feasibility of completing the intangible asset so it can be used or sold Intention of entity to complete the asset and use or sell it How the intangible asset will generate future economic benefits Availability of adequate technical, financial and other resources to complete the development and to use or sell asset Its ability to measure reliably the expenditure attributable to the asset. Baxter plc is preparing its accounts for the year ended 31 May 2009 and is unsure how to treat the following items. 1. The firm completed a big marketing and advertising campaign costing 2.4m. The finance director had authorised this campaign on the basis that it would create 5m of additional profits over the next three years. 2. A new product was developed during the year. The expenditure totalled 1.5m of which 1m was incurred prior to 30 November 2008, the date on which it became clear that the product was technically viable. The new product will be launched in the next four months and its recoverable amount is estimated at 700,000. 3. Staff participated in a training programme which cost the company 300,000. The training organisation had made a presentation to the directors of Baxter outlining that incremental profits to the business over the next twelve months would be 500,000. What amounts should appear as assets in Baxter s statement of financial position as at 31 May 2009?

Solution The treatment in Baxter plc s statement of financial position at 31 May 2009 will be as follows: Marketing and advertising campaign: no asset will be recognised, because it is not possible to identify future economic benefits that are attributable only to this campaign. All of the expenditure should be expensed in the statement of comprehensive income. New product: development expenditure appearing in the statement of financial position will be valued at 500,000. The expenditure prior to the date on which the product becomes technically feasible is recognised in the statement of comprehensive income. Training programme: no asset will be recognised, because staff are not under the control of Baxter plc and when staff leave the benefits of the training, whatever they may be, also leave. Valuation of intangibles after recognition. IAS 38 states that intangible assets can be measured initially at cost, under the cost model, and subsequently carried at cost less accumulated amortisation and impairment losses. The intangible asset can alternatively be included, under the revaluation model, at its fair value less accumulated amortisation and impairment losses. In terms of accounting for revaluation gains and losses the rules are identical to the corresponding rules in IAS16 with regards to revaluation of property, plant and equipment. Example 3 1. Company A acquired an intangible asset on 30 June 2007 for 60,000. The asset was revalued at 80,000 on 30 June 2008 and 45,000 on 30 June 2009. 2. Company B acquired an intangible asset on 30 June 2007 for 90,000. The asset was revalued at 75,000 on 30 June 2008 and at 95,000 on 30 June 2009. Assuming that the year-end for both companies is 30 June, and that they both use the revaluation model, show how each of these transactions should be dealt with in the financial statements. Solution Company A: the 20,000 revaluation increase on 30 June 2008 should be credited to the revaluation reserve and recognised as other comprehensive income. 20,000 of the revaluation decrease on June 2009 should be debited to revaluation reserve and recognised as a (negative figure) in other comprehensive income. The remaining 15,000 should be recognised as an expense. Company B: the 15,000 revaluation decrease on 30 June 2008 should be recognised as an expense. 15,000 of the 20,000 increase on 30 June 2009 should be recognised as income. The remaining 5,000 should be credited to revaluation reserve and recognised as other comprehensive income.

Life of an intangible asset The useful life of intangible assets needs to be assessed as finite or indefinite. An intangible asset with a finite life needs to be amortised on a systematic basis over its life. The useful life of an intangible asset that has arisen from a contract such as a licence or a patent cannot exceed the period of the contract or legal agreement. The method of amortisation, straight line or diminishing balance should reflect the asset usage, be applied consistently and the appropriateness of the remaining life and method should be reviewed on an annual basis. Amortisation should start when the asset is available for use and cease at the earlier of the date the asset is classified as held for sale (IFRS5) and the date the asset is derecognised. If the asset is revalued above cost the increase in amortisation can be transferred from the revaluation reserve to the retained earnings, therefore not impacting on the statement of comprehensive income. Any changes in the expected residual value need to be treated as a change in an accounting estimate as per IAS8. An asset with no foreseeable limit to the period of benefit to the entity can be classified as having an infinite life and will not be amortised. The classification needs to be reviewed for every accounting period. Disclosure The main disclosures required by IAS38 are as follows: For each class of intangible assets, disclosure is required of the following, distinguishing between internally-generated intangibles and other intangibles. The method of amortisation used Useful life of the assets or the amortisation rates used The gross carrying amount, any accumulated amortisation at the beginning and end of the period The line item(s) of the statement of standard comprehensive income in which any amortisation of intangible assets is included A reconciliation of the carrying amount at the beginning and the end of the period. The financial statements should also disclose: In the case of intangible assets that are assessed as having an indefinite useful life, the carrying amounts and the reasons supporting the assessment of indefinite useful life. The carrying amount, nature and amortisation period of any individual intangible asset that is material to the financial statements of the entity as a whole. The accounting policy note from Tesco s 2009 financial statements is as follows: Intangible assets Acquired intangible assets, such as software, pharmacy licences, customer relationships, contracts and brands, are measured initially at cost and are amortised on a straight-line basis over their estimated useful lives, at 2%-100% of cost per annum.

Internally-generated intangible assets Research and development expenditure. Research costs are expensed as incurred. Development expenditure incurred on an individual project is carried forward only if all the criteria set out in IAS 38 Intangible Assets are met, namely: an asset is created that can be identified (such as software or new processes); it is probable that the asset created will generate future economic benefits; and the development cost of the asset can be measured reliably. Following the initial recognition of development expenditure, the cost is amortised over the project s estimated useful life, usually at 14%- 25% of cost per annum. Example 4 As the financial controller of Star plc, a company operating the pharmaceutical sector, you have been provided with the following information by the director of research: Drug Beta Commercial production started on 1 June 2005 for Beta. At 30 November 2008, 50,000 has been capitalised in respect of development expenditure on this drug. During the year a further 10,000 was spent on development of Beta. Star plc have taken out a patent in respect of Beta which will last 8 years. Legal and professional fees in relation to this amounted to 1,600. Current sales of Beta for the year ended 30 November 2009, amounted to 50,000. Sales over the next three years are expected to be 150,000, 220,000 and 100,000 respectively. Drug Alpha The development of this revolutionary drug for the treatment of dementia is at a much earlier stage. The research director of Star plc believes there is real commercial potential and fully expects major profits to arise from this drug. Not all the directors are convinced of the commercial viability of Alpha. Expenditure on this project during the year ended 30 November 2009 amounted to 31,000. Required i. Calculate the total amount to be charged to the statement of comprehensive income in respect of each of the above in the year ended 30 November 2009. ii. Show the movement on intangible assets which would appear in the notes to the financial statements of Star plc for the year ended 30 November 2009.

Solution Total amount to be charged to the statement of comprehensive income for the year ended 30 November 2009: Alpha (not yet qualifying as development phase) 31,000 Amortisation of development costs (Beta) - Working 1 5,769 Amortisation of patent ( 1,600/8) 200 36,969 Notes to the financial statements as at 30 November 2009 (extracts) Intangible assets Development Patents Total Costs Cost At 1 December 2008 50,000-50,000 Additions 10,000 1,600 11,600 At 30 November 2009 60,000 1,600 61,600 Amortisation At 1 December 2008 - - - Charge for year 5,769 200 5,969 At 30 November 2009 5,769 200 5,969 Carrying amount At 1 December 2008 50,000-50,000 At 30 November 2009 54,231 1,400 55,631 Working 1 Sales in year/ total sales x 60,000 50,000 x 60,000 = 5,769 50,000 + 150,000 + 220,000 + 100,000